Canada markets closed

Immunovia AB (publ) (IMMVF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.15000.0000 (0.00%)
At close: 04:07PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,211
1,575
1,145
844
362
Cost of Revenue
5,643
6,682
4,211
-14,969
-40,020
Gross Profit
-4,432
-5,107
-3,066
15,813
40,382
Operating Expenses
Selling General and Administrative
-
-
-
82,607
91,147
Total Operating Expenses
267,258
291,508
188,143
182,554
175,060
Operating Income or Loss
-271,690
-296,615
-191,209
-166,741
-134,678
Interest Expense
-1,698
1,166
1,600
1,432
1,418
Income Before Tax
-260,727
-309,439
-168,092
-155,966
-146,033
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-260,727
-309,439
-168,092
-155,966
-146,033
Net Income
-260,727
-309,439
-168,092
-155,966
-146,033
Net Income available to common shareholders
-260,727
-309,439
-168,092
-155,966
-146,033
Basic EPS
-10.44
-7.38
-6.90
-6.39
-6.35
Diluted EPS
-10.44
-7.38
-6.90
-6.39
-6.35
Basic Average Shares
31,844
41,949
24,386
24,386
22,995
Diluted Average Shares
31,844
41,949
24,386
24,386
22,995